Slide 1: Q1 2026 Earnings Call
Q1 2026 Earnings Call May 7, 2026
Slide 2: Cautionary Statements
Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe
Slide 3: Highlights and Growth Momentum
Highlights and Growth Momentum Puneet Khanna President & Chief Executive Officer
Slide 4: Q1 2026 Summary
Q1 2026 Summary $93.9 Million $1.2 Million Revenue Net Income $8.4 Million 9.0% Adjusted EBITDA1 Adjusted EBITDA Margin1 92,036 Average Beds Serviced1 1. Adjusted EBITDA is a non-IFRS financial measure and Adjusted EBITDA Margin is a non-IFRS ratio. Average Beds Serviced is a is a supplementary fina
Slide 5: Business Highlights
Business Highlights • Received a Public Protector Award by Pharmacy Practice + Business, reflecting our commitment to patient-centered care, continuity of service and responding quickly in complex situations • Named to The Globe and Mail's 2026 Women Lead Here list, recognizing Canadian organization
Slide 6: Operating and Financial Results
Operating and Financial Results Suzanne Brand Chief Financial Officer
Slide 7: Q1 2026 Financial Results
Q1 2026 Financial Results As at March 31, 2026 Average Beds Serviced1 Year-over-year: 92,036 vs 87,675 in Q1 2025 • Revenue increase was primarily driven by the Revenue increase in the number of Average Beds $93.9 million vs $89.6 million in Q1 2025 Serviced¹ Adjusted EBITDA1 • Adjusted EBITDA1, Adj
Slide 8: Q1 2026 Balance Sheet
Q1 2026 Balance Sheet As at March 31, 2026 Quarter-over-quarter: Cash $14.8 million vs $13.9 million at Q4 2025 • Net Debt improved due to higher cash balance and repayment of term loan Net Debt1 • Net Debt to Adjusted EBITDA1 improvement $25.0 million vs $27.1 million at Q4 2025 due to a decrease i
Slide 9: Final Perspectives
Final Perspectives Puneet Khanna President & Chief Executive Officer
Slide 10: Final Perspectives
Final Perspectives • Continue to build momentum as a thought leader through presentations at leading industry conferences like Together We Care 2026 • Celebrating individual achievements among our teams - Dr. Dillon Jayachandran, Clinical Consultant Pharmacist recognized as a Future of Pharmacy Awar
Slide 11: Slide 11